The diagnostic applications segment holds the larger share of the market. These applications are further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology).
The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increasing incidence of overuse sports injuries, rising prevalence of cardiovascular diseases (CVDs) and increasing number of hip and knee replacement surgeries in the country.
Fluoroscopy is a technique that displays multiple x-rays to generate real-time still images or a video of the patient’s body. It is a commonly used medical technique that helps physicians with a wide variety of diagnostic and interventional procedures. The global fluoroscopy equipment market is projected to reach USD 2.79 Billion by 2022 from USD 2.12 Billion in 2016 at a CAGR of 4.8% during the forecast period.
Target Audience:
- Fluoroscopy and C-arms manufacturers and distributors
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
- Medical device vendors/service providers
- Research institutes
- Niche companies manufacturing fluoroscopic imaging systems
- Research and consulting firms
The risk of radiation exposure from fluoroscopy procedures is likely to restrain market growth. Fluoroscopy procedures are time-consuming, which greatly increases the radiation that patients are exposed to and the risk of hazards such as radiation-induced injuries to the skin and underlying tissues. Long-term side effects of prolonged radiation exposure can also include cancer.
The major players in this market include Siemens AG (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd. (China), Agfa-Gevaert Group (Belgium), and Adani Systems Inc. (Belarus)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
